AIMS/HYPOTHESIS: Patient-reported outcome measures (PROMs) are increasingly used as key performance indicators in chronic illness. We sought to review the value of these tools in assessing health-related quality of life (HRQOL) in patients with diabetes-related foot disease and identify the impact of each foot problem on life quality. METHODS: A systematic review of literature on HRQOL PROMs in diabetes-related foot disease was performed according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The quality of eligible studies was evaluated within pre-existing criteria. RESULTS: 53 studies written between 1995 and 2010 met the inclusion criteria. A variety of HRQOL PROMs were used. Disease-specific tools were better than generic at quantifying temporal changes in life quality and showed greater sensitivity to ulcer/neuropathic severity. No studies have simultaneously evaluated disease-specific tools. Generic and utility HRQOL PROMs are frequently used as secondary outcome measures in randomised trials and cost-utility analysis. HRQOL is depressed in diabetes, further impaired by the presence of foot disease. Ulcer healing is associated with improvements in HRQOL. Patients with active ulceration report poorer HRQOL than those whom have undergone successful minor lower extremity amputation (LEA) but there is a paucity of quality data on HRQOL outcomes for diabetes-related LEA. CONCLUSIONS/ INTERPRETATION: No one PROM was identified as a 'gold standard' for assessing HRQOL in diabetes-related foot disease. Specific areas for further development include the most valid HRQOL PROM with disease-specific content; HRQOL outcomes in minor and major amputations and the role of HRQOL tools in routine clinical care.
AIMS/HYPOTHESIS: Patient-reported outcome measures (PROMs) are increasingly used as key performance indicators in chronic illness. We sought to review the value of these tools in assessing health-related quality of life (HRQOL) in patients with diabetes-related foot disease and identify the impact of each foot problem on life quality. METHODS: A systematic review of literature on HRQOL PROMs in diabetes-related foot disease was performed according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The quality of eligible studies was evaluated within pre-existing criteria. RESULTS: 53 studies written between 1995 and 2010 met the inclusion criteria. A variety of HRQOL PROMs were used. Disease-specific tools were better than generic at quantifying temporal changes in life quality and showed greater sensitivity to ulcer/neuropathic severity. No studies have simultaneously evaluated disease-specific tools. Generic and utility HRQOL PROMs are frequently used as secondary outcome measures in randomised trials and cost-utility analysis. HRQOL is depressed in diabetes, further impaired by the presence of foot disease. Ulcer healing is associated with improvements in HRQOL. Patients with active ulceration report poorer HRQOL than those whom have undergone successful minor lower extremity amputation (LEA) but there is a paucity of quality data on HRQOL outcomes for diabetes-related LEA. CONCLUSIONS/ INTERPRETATION: No one PROM was identified as a 'gold standard' for assessing HRQOL in diabetes-related foot disease. Specific areas for further development include the most valid HRQOL PROM with disease-specific content; HRQOL outcomes in minor and major amputations and the role of HRQOL tools in routine clinical care.
Authors: Donna Goodridge; Elly Trepman; Jeff Sloan; Lorna Guse; Laurel A Strain; John McIntyre; John M Embil Journal: Foot Ankle Int Date: 2006-04 Impact factor: 2.827
Authors: J Todd Coffey; Michael Brandle; Honghong Zhou; Deanna Marriott; Ray Burke; Bahman P Tabaei; Michael M Engelgau; Robert M Kaplan; William H Herman Journal: Diabetes Care Date: 2002-12 Impact factor: 19.112
Authors: M E Garay-Sevilla; L E Nava; J M Malacara; R Huerta; J Díaz de León; A Mena; M E Fajardo Journal: J Diabetes Complications Date: 1995 Apr-Jun Impact factor: 2.852
Authors: M Backonja; A Beydoun; K R Edwards; S L Schwartz; V Fonseca; M Hes; L LaMoreaux; E Garofalo Journal: JAMA Date: 1998-12-02 Impact factor: 56.272
Authors: Adriana Lozano-Platonoff; Jose Contreras-Ruiz; Judith Dominguez-Cherit; Andrea Cardenas-Sanchez; Valeria Alvarez-Rivero; Joel A Martínez-Regalado Journal: Int Wound J Date: 2019-11-11 Impact factor: 3.315
Authors: Ellen B M Elsman; Lidwine B Mokkink; Marlous Langendoen-Gort; Femke Rutters; Joline Beulens; Petra J M Elders; Caroline B Terwee Journal: BMJ Open Diabetes Res Care Date: 2022-06
Authors: Xiaoli Zhu; Maja Magdalena Olsson; Ram Bajpai; Krister Järbrink; Wern Ee Tang; Josip Car Journal: Int Wound J Date: 2021-12-02 Impact factor: 3.099
Authors: Tomasz Macioch; Elżbieta Sobol; Arkadiusz Krakowiecki; Beata Mrozikiewicz-Rakowska; Monika Kasprowicz; Tomasz Hermanowski Journal: Health Qual Life Outcomes Date: 2017-01-21 Impact factor: 3.186
Authors: Jennifer J Brown; Shana L Pribesh; Kimberly G Baskette; Aaron I Vinik; Sheri R Colberg Journal: J Diabetes Res Date: 2017-11-08 Impact factor: 4.011
Authors: Sarah Brown; Jane Nixon; Myka Ransom; Rachael Gilberts; Nikki Dewhirst; Elizabeth McGinnis; Roberta Longo; Frances Game; Chris Bojke; Paul Chadwick; Akila Chandrasekar; Ian Chetter; Howard Collier; Catherine Fernandez; Shervanthi Homer-Vanniasinkam; Edward Jude; Richard Leigh; Richard Lomas; Peter Vowden; James Wason; Linda Sharples; David Russell Journal: BMJ Open Date: 2020-04-19 Impact factor: 2.692